Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H30N2O2 |
| Molecular Weight | 306.443 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCN(CCCC)CCCOC(=O)C1=CC=C(N)C=C1
InChI
InChIKey=HQFWVSGBVLEQGA-UHFFFAOYSA-N
InChI=1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3
| Molecular Formula | C18H30N2O2 |
| Molecular Weight | 306.443 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12174527
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12174527
Butacaine is a local anesthetic. It should not be used with people who have a history of allergies due to the possibility of anaphylactic shock.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Solubility-excipient classification gradient maps. | 2007-03 |
|
| PAMPA - excipient classification gradient map. | 2006-11 |
|
| Managing patients with local anesthetic complications using alternative methods. | 2002-08-15 |
|
| Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. | 2001-04-15 |
|
| Keratitis from misuse of corneal anesthetics. | 1968-08-22 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6240271
The specific activities of two transferases, aspartate-amino-transferase and creatine phosphokinase, are increased by 10(-5) mol/l butacaine
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:48 GMT 2025
by
admin
on
Mon Mar 31 18:26:48 GMT 2025
|
| Record UNII |
Z84S23CGJJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
||
|
CFR |
21 CFR 524.1580C
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C87457
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
758632
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
DB11502
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
205-734-7
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
m2780
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
Z84S23CGJJ
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
BUTACAINE
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
2480
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
100000088471
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
CHEMBL129529
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
381
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
DTXSID3045300
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
SUB05994MIG
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
149-16-6
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | |||
|
1829
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY | RxNorm | ||
|
3050
Created by
admin on Mon Mar 31 18:26:48 GMT 2025 , Edited by admin on Mon Mar 31 18:26:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |